A global business that’s all about sleep

Rob Douglas is the Chief Operating Officer of ResMed which has been a fantastic stock for investors, particularly over the last six years when it’s delivered a 30% compound growth rate in the share price since this time in 2016. Alan Kohler spoke to Rob to find out why.

Become a TCI Community Member Now

Stay up to date and make better informed decisions.
Get access to all this exclusive content and so much more every week!

  • $1 for the first month
  • $25/month membership
  • Cancel anytime, no lock in contract
  • Access to Private Facebook group
  • Smartphone App (coming soon)